Juniper Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch JNP and buy or sell other stocks, options, and ETFs commission-free!

About JNP

Juniper Pharmaceuticals (Nasdaq: JNP) is developing therapeutics that address unmet medical needs in women’s health. Their current pipeline leverages the 505(b)(2) regulatory pathway with new formulations of existing pharmaceuticals. 

CEO
John R. Chiminski
CEOJohn R. Chiminski
Employees
Employees
Headquarters
Somerset, New Jersey
HeadquartersSomerset, New Jersey
Founded
1986
Founded1986
Employees
Employees

JNP Key Statistics

Market cap
127.71M
Market cap127.71M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
81.86K
Average volume81.86K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$13.25
52 Week high$13.25
52 Week low
$4.30
52 Week low$4.30
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.